These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3273250)

  • 21. Impact of dose rate on clinical course in uveal melanoma after brachytherapy with ruthenium-106.
    Mossböck G; Rauscher T; Winkler P; Kapp KS; Langmann G
    Strahlenther Onkol; 2007 Oct; 183(10):571-5. PubMed ID: 17896089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technique of ruthenium-106 application in the treatment of conjunctival melanoma.
    Steinkogler FJ; Binder W; Seitz W
    Strahlenther Onkol; 1987 Dec; 163(12):787-90. PubMed ID: 3424078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cobalt plaque therapy--a conservative approach to posterior uveal melanoma.
    Easterlin MN
    J Ophthalmic Nurs Technol; 1986; 5(4):140-2. PubMed ID: 3636412
    [No Abstract]   [Full Text] [Related]  

  • 26. Uveal malignant melanoma with extrascleral extension, treated with plaque radiotherapy.
    Muen WJ; Damato BE
    Eye (Lond); 2007 Feb; 21(2):307-8. PubMed ID: 16946742
    [No Abstract]   [Full Text] [Related]  

  • 27. Sympathetic ophthalmia after ruthenium plaque brachytherapy.
    Ahmad N; Soong TK; Salvi S; Rudle PA; Rennie IG
    Br J Ophthalmol; 2007 Mar; 91(3):399-401. PubMed ID: 17322472
    [No Abstract]   [Full Text] [Related]  

  • 28. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
    Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
    J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does the imaging method have an influence on the measured tumor height in ruthenium plaque therapy of uveal melanoma?
    Schueller P; Dogan A; Panke JE; Micke O; Willich N
    Strahlenther Onkol; 2005 May; 181(5):320-5. PubMed ID: 15900429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Echographic evaluation of malignant melanoma of the uvea following ruthenium therapy].
    Kissinger A; Bornfeld N; Foerster MH; Gerke E; Wessing A; Meyer-Schwickerath G
    Fortschr Ophthalmol; 1986; 83(6):721-5. PubMed ID: 3546039
    [No Abstract]   [Full Text] [Related]  

  • 31. [The analysis of I125 brachytherapy complications in cases of uveal melanoma].
    Pogrzebielski A; Starzycka M; Romanowska-Dixon B; Jakubowska B; Szpakowicz U
    Klin Oczna; 2005; 107(1-3):49-53. PubMed ID: 16052800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy.
    Summanen P; Immonen I; Heikkonen J; Tommila P; Laatikainen L; Tarkkanen A
    Ophthalmic Surg; 1993 Feb; 24(2):82-90. PubMed ID: 8446359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Techniques and results of 106Ru/106Rh radiation of choroidal tumours.
    Busse H; Müller RP
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():72-7. PubMed ID: 6581639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation therapy for uveal malignant melanoma.
    Shields CL; Shields JA; Gündüz K; Freire JE; Mercado G
    Ophthalmic Surg Lasers; 1998 May; 29(5):397-409. PubMed ID: 9599365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
    Detorakis ET; Engstrom RE; Wallace R; Straatsma BR
    Ophthalmology; 2005 Mar; 112(3):505-10. PubMed ID: 15745782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual outcome of eyes with malignant melanoma of the uvea after ruthenium plaque radiotherapy.
    Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
    Ophthalmic Surg Lasers; 1995; 26(5):449-60. PubMed ID: 8963860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
    Puusaari I; Heikkonen J; Kivelä T
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
    Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
    Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strabismus in adults with uveal melanoma following episcleral plaque brachytherapy.
    Dawson E; Sagoo MS; Mehta JS; Comer R; Hungerford J; Lee J
    J AAPOS; 2007 Dec; 11(6):584-8. PubMed ID: 17588793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Radio-adhibition therapy of uveal melanoma: current status].
    She HC
    Zhonghua Yan Ke Za Zhi; 2003 Feb; 39(2):125-8. PubMed ID: 12795272
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.